On Thursday, January 25, the team at Premier Pain Treatment Institute celebrated the grand opening of their new Middletown, Ohio location with an open house and ribbon cutting ceremony. The event was attended by local physicians, pharmaceutical representatives, staff members from the City of Middletown, and the honorable Mayor Elizabeth Slamka. Also in attendance were two of Premier Pain Treatment Institute’s physicians who will be working in the Middletown office: Dr. Michael Danko and Dr. Joseph Wray.
Located at 4701 Central Avenue in Middletown, Ohio and formerly occupied by Cincinnati Eye Institute, the building features nearly twenty patient rooms. An on-site fluoroscopy room allows patients to receive minimally invasive procedures without the need to visit a separate location.
“We’re very excited to be a part of the strong Middletown community and bring our expertise in pain management to Middletown and the neighboring areas. At Premier Pain Treatment Institute, we’re dedicated to providing compassionate, personalized care that helps our patients reclaim their lives and get back to doing what they love,” said Kyle Ingebritson, Chief Executive Officer of PPTI.
Currently, the Middletown location will be open every Tuesday in February, as well as some Mondays and additional days as needed. As Spring approaches, the office will expand to a full operating schedule, with patient appointments scheduled Mondays through Thursdays.
Premier Pain Treatment Institute specializes in the treatment of pain caused by chronic medical conditions and cancer, with the goal of not only providing pain relief, but also quality of life. The new Middletown location is PPTI’s fourth, with offices also located in Hillsboro, Loveland, and Mt. Orab, Ohio.
If you’re interested in becoming a new patient at any of Premier Pain Treatment Institute’s four locations, please call 513-454-7246. If you’d like to apply to join an ever-expanding team, fill out a contact form and someone from the PPTI team will be in touch!
Last Updated: February 1, 2024
